Stephen Ayers | VERA Vera Therapeutics Atacicept: Promising Step In IgAN, But Crowded Road Ahead (Rating Downgrade) ByMario Cazombo June 4, 2025
AAAU | BAR | BGLD | DBP | Dean Popplewell | GBUG | GLD | GLDI | GLDM | GLTR | IAU | IAUM | IGLD | JJP | OUNZ | PHYS | SGOL | XAUUSD:CUR Gold Surges On Safe-Haven Demand – On Track For New All-Time Highs? ByMario Cazombo June 3, 2025
BABA | BABAF | CAIXY | CIXPF | GLAXF | GSK | ING | ISG | JSNSF | Mutual Fund Commentaries | OTPGF | Pzena Investment Management | SCBFF | TTDKF Pzena International Value ADR Q1 2025 Commentary ByMario Cazombo May 27, 2025
Bert Hochfeld | NBIS Nebius: Explosive Growth At What Is Still A Reasonable Valuation ByMario Cazombo June 5, 2025